Barrier Therapeutics Anno

Barrier Therapeutics, Inc., a pharmaceutical company developing and commercializing products in the field of dermatology, today announced its financial results for the fourth quarter ended December 31, 2005. Net loss for the quarter was $10.2 million which represents a loss of $0.43 per share. Full year 2005 net loss was $45.2 million which represents a loss of $1.91 per share.